Home Healthcare Medical Devices Ambulatory Polysomnography (Psg) Systems Market

Ambulatory Polysomnography (Psg) Systems Market Size, Share & Trends Analysis Report By Product (Up to 12-channel PSG systems, Up to 24-channel PSG systems, Up to 32-channel PSG systems, Above 32-channel PSG systems), By Application (Obstructive Sleep Apnea, Chronic Insomnia, Narcolepsy, Periodic Limb Movement Disorders, Sleep-related Seizures, Snoring), By End User (Hospitals, Sleep Laboratories, Home Care Settings) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 27, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Ambulatory Polysomnography (Psg) Systems Market, By Product 2025-2034 (USD MILLION/ Units)
    1. Up to 12-channel PSG systems
    2. Up to 24-channel PSG systems
    3. Up to 32-channel PSG systems
    4. Above 32-channel PSG systems
  2. Ambulatory Polysomnography (Psg) Systems Market, By Application 2025-2034 (USD MILLION/ Units)
    1. Obstructive Sleep Apnea
    2. Chronic Insomnia
    3. Narcolepsy
    4. Periodic Limb Movement Disorders
    5. Sleep-related Seizures
    6. Snoring
  3. Ambulatory Polysomnography (Psg) Systems Market, By End User 2025-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Sleep Laboratories
    3. Home Care Settings
  4. Regional Ambulatory Polysomnography (Psg) Systems Market
    1. North America
      1. North America Ambulatory Polysomnography (Psg) Systems Market By Product 2025-2034 (USD MILLION/ Units)
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
      2. North America Ambulatory Polysomnography (Psg) Systems Market By Application 2025-2034 (USD MILLION/ Units)
        1. Obstructive Sleep Apnea
        2. Chronic Insomnia
        3. Narcolepsy
        4. Periodic Limb Movement Disorders
        5. Sleep-related Seizures
        6. Snoring
      3. North America Ambulatory Polysomnography (Psg) Systems Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Sleep Laboratories
        3. Home Care Settings
      4. U.S.
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      5. Canada
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
    2. Europe
      1. Europe Ambulatory Polysomnography (Psg) Systems Market By Product 2025-2034 (USD MILLION/ Units)
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
      2. Europe Ambulatory Polysomnography (Psg) Systems Market By Application 2025-2034 (USD MILLION/ Units)
        1. Obstructive Sleep Apnea
        2. Chronic Insomnia
        3. Narcolepsy
        4. Periodic Limb Movement Disorders
        5. Sleep-related Seizures
        6. Snoring
      3. Europe Ambulatory Polysomnography (Psg) Systems Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Sleep Laboratories
        3. Home Care Settings
      4. U.K.
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      5. Germany
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      6. France
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      7. Spain
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      8. Italy
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      9. Russia
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      10. Nordic
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      11. Benelux
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      12. Rest of Europe
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
    3. APAC
      1. APAC Ambulatory Polysomnography (Psg) Systems Market By Product 2025-2034 (USD MILLION/ Units)
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
      2. APAC Ambulatory Polysomnography (Psg) Systems Market By Application 2025-2034 (USD MILLION/ Units)
        1. Obstructive Sleep Apnea
        2. Chronic Insomnia
        3. Narcolepsy
        4. Periodic Limb Movement Disorders
        5. Sleep-related Seizures
        6. Snoring
      3. APAC Ambulatory Polysomnography (Psg) Systems Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Sleep Laboratories
        3. Home Care Settings
      4. China
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      5. Korea
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      6. Japan
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      7. India
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      8. Australia
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      9. Taiwan
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      10. South East Asia
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      11. Rest of Asia-Pacific
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
    4. Middle East and Africa
      1. Middle East and Africa Ambulatory Polysomnography (Psg) Systems Market By Product 2025-2034 (USD MILLION/ Units)
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
      2. Middle East and Africa Ambulatory Polysomnography (Psg) Systems Market By Application 2025-2034 (USD MILLION/ Units)
        1. Obstructive Sleep Apnea
        2. Chronic Insomnia
        3. Narcolepsy
        4. Periodic Limb Movement Disorders
        5. Sleep-related Seizures
        6. Snoring
      3. Middle East and Africa Ambulatory Polysomnography (Psg) Systems Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Sleep Laboratories
        3. Home Care Settings
      4. UAE
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      5. Turkey
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      6. Saudi Arabia
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      7. South Africa
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      8. Egypt
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      9. Nigeria
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      10. Rest of MEA
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
    5. LATAM
      1. LATAM Ambulatory Polysomnography (Psg) Systems Market By Product 2025-2034 (USD MILLION/ Units)
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
      2. LATAM Ambulatory Polysomnography (Psg) Systems Market By Application 2025-2034 (USD MILLION/ Units)
        1. Obstructive Sleep Apnea
        2. Chronic Insomnia
        3. Narcolepsy
        4. Periodic Limb Movement Disorders
        5. Sleep-related Seizures
        6. Snoring
      3. LATAM Ambulatory Polysomnography (Psg) Systems Market By End User 2025-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Sleep Laboratories
        3. Home Care Settings
      4. Brazil
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      5. Mexico
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      6. Argentina
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      7. Chile
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      8. Colombia
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
      9. Rest of LATAM
        1. Up to 12-channel PSG systems
        2. Up to 24-channel PSG systems
        3. Up to 32-channel PSG systems
        4. Above 32-channel PSG systems
        5. Obstructive Sleep Apnea
        6. Chronic Insomnia
        7. Narcolepsy
        8. Periodic Limb Movement Disorders
        9. Sleep-related Seizures
        10. Snoring
        11. Hospitals
        12. Sleep Laboratories
        13. Home Care Settings
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.